Internal Medicine, Rheumatology · Bowling Green, KY
NPI
1659534071
Since 2008
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2724 Nashville Rd
Bowling Green, KY, 42101
Phone (270) 780-5226
Groups this clinician bills Medicare through
Medicare paid, 2024
$990K
71,254 services
Medicare patients, 2024
450
Average age 72
Drug cost, 2024
$4.2M
4,316 prescriptions
Company payments, 2025
$9,469
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Neha Pansuria was code J0129 (injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 10,100 times for 15 patients. In total Neha Pansuria billed 71,254 services in 137 codes, and Medicare paid $990K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-05-29.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 10,100 | 15 | $33.91 | $342K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 3,710 | 18 | $24.07 | $89K |
| J0897 Injection, denosumab, 1 mg | Office | 2,040 | 27 | $20.41 | $42K |
| 99214 Office E&M - Established | Office | 1,123 | 378 | $83.58 | $94K |
| 86140 Clinical Chemistry | Office | 849 | 329 | $5.04 | $4,280 |
| 80053 Clinical Chemistry | Office | 812 | 321 | $10.27 | $8,342 |
| 85025 Blood Count | Office | 742 | 317 | $7.57 | $5,617 |
| 85652 Clinical Chemistry | Office | 672 | 296 | $2.64 | $1,771 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 616 | 74 | $0.69 | $425 |
| 96365 Intravenous Infusion, Hydration | Office | 207 | 36 | $41.39 | $8,567 |
| 96415 Chemotherapy Administration | Office | 160 | 29 | $19.41 | $3,106 |
| 96413 Chemotherapy Administration | Office | 159 | 29 | $86.98 | $14K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 102 | 91 | $12.65 | $1,290 |
| 84550 Clinical Chemistry | Office | 98 | 50 | $4.43 | $434 |
| 86160 Immunoassay | Office | 79 | 32 | $11.76 | $929 |
By year: 2022 $925K for 63,304 services; 2023 $976K for 62,530 services; 2024 $990K for 71,254 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 86140 Clinical Chemistry | 849 | 329 | $5.04 | $4,280 |
| 80053 Clinical Chemistry | 812 | 321 | $10.27 | $8,342 |
| 85025 Blood Count | 742 | 317 | $7.57 | $5,617 |
| 85652 Clinical Chemistry | 672 | 296 | $2.64 | $1,771 |
| 84550 Clinical Chemistry | 98 | 50 | $4.43 | $434 |
| 86160 Immunoassay | 79 | 32 | $11.76 | $929 |
| 86431 Immunoassay | 77 | 69 | $5.51 | $424 |
| 86235 Immunoassay | 54 | 23 | $17.10 | $923 |
| 86200 Immunoassay | 52 | 52 | $12.69 | $660 |
| 82306 Clinical Chemistry | 36 | 34 | $29.01 | $1,044 |
Medicare prescription drug claims, 2024
In 2024, the drug Neha Pansuria prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 833 prescriptions and refills. In total Neha Pansuria wrote 4,316 Medicare prescriptions that cost $4.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 833 | 949 | 197 | $7,431 |
| Hydroxychloroquine Sulfate Generic | 519 | 685 | 144 | $5,330 |
| Prednisone Generic | 359 | 385 | 170 | $1,209 |
| Gabapentin Generic | 264 | 284 | 46 | $848 |
| Celecoxib Generic | 218 | 300 | 83 | $6,021 |
| Sulfasalazine Generic | 179 | 237 | 49 | $2,468 |
| Enbrel Sureclick Etanercept | 164 | 167 | 22 | $1.2M |
| Tramadol Hcl Generic | 143 | 150 | 38 | $468 |
| Alendronate Sodium Generic | 139 | 173 | 51 | $639 |
| Allopurinol Generic | 134 | 202 | 43 | $518 |
| Methotrexate Sodium Methotrexate Sodium/Pf | 133 | 155 | 34 | $1,290 |
| Duloxetine Hcl Generic | 109 | 156 | 41 | $1,258 |
| Diclofenac Sodium Generic | 107 | 123 | 48 | $1,569 |
| Leflunomide Generic | 86 | 99 | 23 | $3,209 |
| Humira(Cf) Pen Adalimumab | 75 | 82 | 14 | $573K |
Brand drugs: - claims; generic drugs: 3,505 claims; opioid claims: 145.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Neha Pansuria $9,469 ($9,469 in general payments such as food, travel and fees) from 23 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $6,219.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $6,219 |
| Amgen Inc. AMGN | 43 | $800 |
| UCB, Inc. UCB.BR | 28 | $524 |
| Abbvie Inc. ABBV | 20 | $417 |
| Janssen Biotech, Inc. JNJ | 9 | $236 |
| Mallinckrodt Hospital Products Inc. | 10 | $178 |
| E.R. Squibb & Sons, L.L.C. BMY | 7 | $156 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $151 |
| GlaxoSmithKline, LLC. GSK | 6 | $145 |
| Janssen Scientific Affairs, LLC JNJ | 1 | $111 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.